Inhibitory SGLT2 – nowe doustne leki przeciwcukrzycowe Journal title: Postępy Nauk Medycznych Authors: Bernadetta Kałuża, Edward Franek Subject(s):
SGLT2 inhibitors – new oral hypoglycemic drugs Journal title: Postępy Nauk Medycznych Authors: Bernadetta Kałuża, Edward Franek Subject(s):
Inhibitors of type 2 sodium glucose co-transporters - a new strategy for diabetes treatment. Journal title: Pharmacological Reports Authors: Aleksandra Bołdys, Bogusław Okopień Subject(s):
On The Horizon: New Oral Therapies for Type 2 Diabetes Mellitus Journal title: International Journal of Diabetology & Vascular Disease Research (IJDVR) Authors: Intekhab Ahmed Subject(s):
Drugs affecting the incretin system and renal glucose transport: do they meet the expectations of modern therapy of type 2 diabetes? Journal title: Advances in Hygiene and Experimental Medicine Authors: Anna Gumieniczek Subject(s): Medicine
Leki wpływające na układ inkretynowy i nerkowy transport glukozy: czy spełniają oczekiwania nowoczesnej terapii cukrzycy typu 2? Journal title: Advances in Hygiene and Experimental Medicine Authors: Anna Gumieniczek Subject(s): Medicine
Dapagliflozin- Induced Severe Ketoacidosis Requiring Hemodialysis Journal title: Clinical Medical Reviews and Case Reports Authors: Subject(s):
Safety of Sodium-Glucose Cotransporter 2 Inhibitors (SGLT2-I) During the Month of Ramadan in Muslim Patients with Type 2 Diabetes Journal title: Oman Medical Journal Authors: Alaaeldin Bashier, Azza Abdulaziz Khalifa, Elamin Ibrahim Abdelgadir, Maryam Ahmad Al Saeed, Amina A... Subject(s):
Risk and Benefits of Canagliflozin, a New Sodium-Glucose Co-Transporter Type 2 Inhibitor, in the Treatment of type-2 Diabetes Mellitus Journal title: International Journal of Science and Research (IJSR) Authors: Subject(s):
The Combination of Canagliflozin with a Half-Dose of Glimepiride Improves Glycemic Control and Blood Glucose Perturbation without Increasing the Risk of Hypoglycemia and Ketosis Journal title: International Journal of Diabetes and Clinical Research Authors: Subject(s):
ЗАСТОСУВАННЯ ІНГІБІТОРІВ SGLT-2 ДЛЯ КОРЕКЦІЇ ПРОЯВІВ ГІПЕРУРИКЕМІЇ ТА НИРКОВОЇ ДИСФУНКЦІЇ У ХВОРИХ НА ЦУКРОВИЙ ДІАБЕТ 2 ТИПУ Journal title: World Science Authors: В. В. Корпачев, О. В. Зінич, Н. М. Кушнарьова, А. В. Ковальчук Subject(s):
SGLT2 inhibition in patients with type 2 diabetes and cardiovascular diseases: which are the benefits? Journal title: Revista de Medicină Militară Authors: Camelia Diaconu, Teodor Salmen, Mihnea A Gaman, Ovidiu Bratu, Dan Mischianu, D Marcu, Andra I Suceve... Subject(s):
Predictors of outcome of cerebral venous sinus thrombosis at a tertiary care centre in Central India Journal title: Panacea Journal of Medical Sciences Authors: Madhuri Holay, Rajashree Khot, Amit Bhatti, Madhuri Paithankar Subject(s):
New Hypoglycaemic Drugs for the Treatment of Diabetes Mellitus and Its Complications: The Future is coming. Journal title: Open Access Journal of Urology & Nephrology Authors: Alberto Martínez-Castelao Subject(s):
Comparison of Diuretic Effects between Empagliflozin, a Sodium-Glucose Co-Transporter 2 Inhibitor With Osmotic Diuresis, and Tolvaptan, a Water Diuretic, in Two Type 2 Diabetic Patients Taking Sodium Diuretics Journal title: Diabetes Research – Open Journal Authors: Yuji Aoki Subject(s):
